| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8538662 | Toxicology and Applied Pharmacology | 2018 | 33 Pages |
Abstract
AFPep is effective for the treatment of ER-positive breast cancer and exhibits a therapeutic index that is substantially wider than that for drugs currently in clinical use. The data emphasize the importance of pursuing pre-clinical toxicology studies with the intent to enter clinical trials.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Wasila Mansouri, Samuel B. Fordyce, Matthew Wu, David Jones, Douglas Cohn, Qishan Lin, Paul Feustel, Tanuj Sharma, James A. Bennett, Thomas T. Andersen,